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Abstract 
 
Background: The emergence and spread of extended spectrum β-lactamase (ESBL)-producing Gram- negative bacteria 
(GNB), particularly in Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa, have increased all over 
the world. ESBLs are characterized by their ability to hydrolyze β-lactams, early cephalosporins, oxyimino-thiazolyl 
cephalosporins, and monobactams, but not cephamycins or carbapenems. The rate of nosocomial infections caused by 
ESBL-producing GNB in Asia Pacific has increased and several studies have identified their prevalence in the region. The 
aim of this study is to review the prevalence of ESBL-producing GNB in the West Asia and the Middle East with a 
particular focus on Iran. 
Materials and Methods: The available evidence from various studies (Microbia and clinical studies, retrieved from the 
PubMed, and Scopus databases) regarding the ESBL producing Gram negative bacteria in Iran were evaluated. 
Results: In almost all parts of the country, high resistance has been observed, especially in the central part of Iran. Up to 
89.8% Escherichia coli, 72.1% Klebsiella pneumonia, 84.2% Acinetobacter baumannii, and 83.8% Pseudomonas 
aeruginosa isolates are ESBL positive. 
Conclusion: The present study showed the increasing prevalence of ESBLs in different regions of Iran, which could be 
useful to strategic policy towards reducing reduce their prevalence. 
 
Keywords: extended-spectrum β-lactamase; antibiotic resistance; Acinetobacter baumannii; Pseudomonas aeruginosa; 
Iran. 
 
Introduction 
 
Infections due to Gram negative bacteria (GNB) are causing morbidity and mortality worldwide, and the 
production of β-lactamase remains the most important contributing factor to β-lactam resistance (Leylabadlo et al., 2016). 
Nowadays, the rapid spread of resistance to β-lactam antibiotics among GNB poses a clinical and public health challenge 
and increasing rates of drug resistance among them is a major concern worldwide (Little et al., 2012). Monobactams, 
cephalosporins, penicillins, and carbapenems can be hydrolyzed by the enzymes of the β- lactamase group, which renders 
them microbiologically ineffective (Bush and Mobashery, 1998). In the early 1980s, new family of beta-lactamases named 
extended-spectrum β-lactamases (ESBLs) were identified introduced that hydrolyze penicillins and expanded-spectrum 
cephalosporins have emerged (Kliebe et al., 1985). They are effective against β-lactam antibiotics like ceftazidime, 
ceftriaxone, cefotaxime, and oxyiminomonobactam, but not cephamycins or carbapenems (Bradford, 2001). ESBL 
production has been associated with Enterobacteriaceae, mostly Klebsiella pneumoniae isolated from Intensive care unit 
(ICU) patients; however, it is found also in community setting (Paterson and Bonomo, 2005) and, more recently, other 
Gram negative bacteria such as Acinetobacter baumannii and Pseudomonas aeruginosa (Oliver et al., 2005). 
Nowadays, more than 600 ESBL variants have been described, the majority of which belong to the Cefotaxime 
hydrolyzing capabilities (CTX-M), Sulfhydryl variable (SHV) and Temoneira (TEM) 
(http://www.lahey.org/studies/webt.htm). Most of the detected ESBLs are either of SHV or TEM types and associated with 
nosocomial infections caused by Gram negative bacteria (Paterson and Bonomo 2005). In the recent years, the spread of 
CTX-M-producing E. coli has been dramatic and they are considered the primary ESBL producers that are always 
associated with community-acquired infections (Leylabadlo et al., 2015). 
Generally, ESBL has been found all over the world; for example, previous studies have reported that the 
prevalence of ESBL in Europe is higher than the United States, but lower than South America and Asia (Giamarellou, 
2005). Asia is almost certainly a part of the world, in which the prevalence of ESBLs is very high among GNBs; however, 
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different countries have different prevalence rates (Giamarellou, 2005). The prevalence of ESBL in GNB has been 
previously reviewed in the countries of Gulf Cooperation Council (GCC) in the West of Asia and the Middle East (Zowawi 
et al., 2013), but did not included Iran, a country in both the West of Asia and in the Middle East, which also is another 
Persian Gulf country. Therefore, this review is focused on obtaining Iranian ESBL epidemiology and population structure 
of ESBL- producing isolates from hospitals and communities. Also, we have attempted to analyze the nature of mobile 
genetic elements carrying ESBL genes. 
 
Material and Methods 
  
We conducted a search in the field using the Scopus, PubMed, Google Scholar, and Persian Databases from 2008 
to 2016. 
 
Prevalence of ESBLs-producing GNB in Iran 
 
Iran, a country in the western Asia, is the second largest nation in the Middle East. The country is bordered by 
Azerbaijan and Armenia in the northwest, Russia and Kazakhstan across the Caspian Sea, Turkmenistan in the northeast, 
Afghanistan and Pakistan in the east, the Gulf of Oman and the Persian Gulf in the south, and Turkey and Iraq in the west. 
Iran is divided into five regions with thirty-one provinces and various climatic conditions. For convinience of study, we 
divided it into five hypothetical parts: Northern (Mazandaran, Guilan, and Golestan Provinces), Southern (Kerman, 
Khuzestan, Yazd, Fars, Hormazgan, Bushehr, as well as Kohgiluyeh and Boyer Ahmad Provinces), Central (Tehran, 
Isfahan, Makazi, Zanjan, Semnan, Chaharmahal and Bakhtiari , Qom, Qazvin, and Alborz Provinces), Eastern (Khorasan 
Razavi, Northern and Southern Khorasan, as well as Sistan and Baluchestan Provinces), and Western (Hamedan, Ilam, 
Kermanshah, Kurdistan, East Azerbaijan, Ardebil, West Azerbaijan, and Lorestan Provinces). There are several studies 
about the prevalence of ESBL-producing bacteria from most provinces in Iran. Nevertheless, in some provinces 
(Hormazgan, Kohgiluyeh and Boyer Ahmad, Qom, Northern and Southern Khorasan, as well as Bushehr), no reports are 
available. Spread and prevalence of ESBLs-producing bacteria are shown in Figure 1. 
 
 
 
Figure 1: Representation of the frequency of ESBL production (no. of tested isolates) and types of ESBLs produced by 
GNB isolates from Iranian hospitals and communities. Distribution of ESBLs was not available for all the studies reporting 
prevalence data.  
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Northern part of Iran 
 
In the north of Iran, several surveys have been conducted among ESBL-producing GNB isolates from the 
community and hospitals. A study in Mazandaran Province, which was carried out at Buali Sina Hospital, revealed that 100 
out of 327 uropathogenic E. coli (30.5%) were positive for ESBL that were lower in other Asian countries such as India 
(27%) (Ananthan and Subha 2005). Also, in the same study, TEM gene was the most prevalent one (49%) followed by 
other genes and about 12% of ESBL-producing isolates were shown to have both TEM and CTX-M genes. In another study 
from the region, to identify the accompanying Class 1 integrons and ESBLs in the MDR E. coli isolates, urine samples 
were collected (Moghaddam et al., 2015). The isolates were different in the resistance profiles; however, some others had 
similar resistance profiles. In a recent study, there was a significant correlation between ESBL production and resistance to 
all types of antibiotics except for piperacillin and ciprofloxacin, and out of eight ESBL positive isolates, seven (87.5%) 
carried class 1 integrons (Moghaddam et al., 2015). In another study from pediatric patients for ESBL genes, about 30.5% 
of isolated E. coli were ESBL-positive and TEM gene was identified in 49% followed by CTX in 28%, SHV in 44%, VEB 
in 8%, and GES in 0% of isolates (Rezai et al., 2015). 
The analysis of 100 ESBL phenotypes of A. baumannii from the clinical samples of some hospitals in Mazandaran 
Province, representing the molecular pattern of Acinetobacter spp., 24% of the isolates were positive, which 79.1% were 
blaTEM and 31.5% were blaCTX (Ahanjan et al., 2014). The prevalence of blaTEM in this study was the same as reported in 
China (Jin et al., 2009). In a study from Babol city in Mazandaran during 2011-2012, a high prevalence of β-lactamase-
producing E.coli was reported in the hospital, having two or three different types of enzymes in a bacterium, the lowest of 
which was related to Plasmid-Encoded AmpC (pAmpC) enzyme in 20 (7.7%) isolates (Shahandeh et al., 2015). This value 
was different from Indian study with the prevalence of 48.5% (Nagdeo et al., 2012). 
A study in Guilan Province on urine samples revealed that 55% of E. coli isolates were resistant to the third and 
fourth cephalosporins. In a similar study on the urine samples of hospitalized patients and outpatients of Valiasr Hospital, 
the incidence of ESBL was 38.92% and bacterial isolates had the highest levels of resistance to amoxicillin, cephalexin, and 
tetracycline (Ranjbar et al., 2014). Another province in the northern part of Iran is Golestan Province. In a study carried out 
on urine samples of the outpatients, 70 isolates (32.1%) were resistant to cefotaxim and 62 (88.6%) were confirmed as 
ESBL-producing E.coli (NasrolahiOmran et al., 2012). Also, the prevalence of ESBL-producing E.coli in Golestan was in 
the range of the country's average and blaCTX-M gene was the most common one (NasrolahiOmran et al., 2012). 
In general, class A and D as well as AmpC β-lactamases are the most common in the northern part of Iran. The prevalence 
of ESBLs was between 24 and 56.85% among the samples of both hospitals and the community. Also, this prevalence was 
33.77% in the north of Iran on average. The highest rate belonged to a hospital in Babol city in the north of Iran, which was 
also mentioned in the present work (Table 1). 
 
Table 1: Summary of ESBL enzymes and their rates identified in the Iran.All listed studies used phenotypic methods such 
as double-disk synergy test (DDST) or ESBL Etest 
Section and 
Province         
 
Producing 
organism 
Setting  ESBL genotypes  (%)among 
ESBL  
Reference 
 
Northern part of  Iran  
Mazandaran E. coli Hospital and 
Community 
 
TEM, SHV, CTX, 
VEB 
 
(30.5) (Rezai et al., 2014) 
 
Mazandaran A. baumannii 
 
Hospital TEM, CTX  
 
(24) (Ahanjan et al., 2014) 
Mazandaran E. coli Hospital 
 
AmpC   (56.8) (Shahandeh et al., 
2015) 
Guilan E. coli not specified  CTX-M (24) 
 
(Hemmati et  al., 
2015) 
Guilan E. coli Hospital and 
Community 
  
Not analyzed (38.9) (Ranjbar et al., 2014) 
Golestan E. coli Community 
 
CTX-M , TEM , 
SHV 
 
(28.4) (Nasrolahi et al., 
2012) 
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Southern part of  Iran 
Kerman P.aeruginosa Hospital  
 
SHV, PER, TEM  
 
(34) ( Shakibaie et al., 
2008) 
Kerman K. pneumoniae 
E. coli 
Hospital  
 
CTX-M, AmpC 
 
(43.8) (Mansouri et al., 
2014) 
Kerman P.aeruginosa 
A. baumannii 
 
Hospital  
 
CTX-M  (59.4) (Mansouri et al., 
2012) 
Kerman P.aeruginosa Hospital  
 
CTX-M , VEB-1, 
PER-1,  
GES-1, OXA-4, 
OXA-10 
 
(34.1) (Shacheraghi et al., 
2010) 
Khuzestan  Enterobacteriac
eae 
Hospital and 
Community 
 
TEM , SHV 
 
(30.5) (Moosavian and 
Deiham 2012) 
Khuzestan K. pneumoniae Hospital 
 
CTX-M1 
  
(47.72) (Khosravi et al., 
2013) 
Khuzestan P.aeruginosa Hospital  
 
PER-1, OXA-10, 
CTX-M 
 
(51.9) (Farshadzadeh et al., 
2014) 
Yazd P.aeruginosa Hospital 
 
Not analyzed (22) (Tafti et al., 2014) 
Fars K. pneumoniae Hospital  
 
TEM, CTX-M 
 
(60) (Ghasemi, Archin et 
al.) 
Fars  Gram negative 
bacil 
Community 
 
TEM, SHV  
 
(11.75) (Kargar et al., 2014) 
Centeral part of  Iran  
Tehran E. coli Hospital  
 
TEM, SHV  
 
(28) (Pakzad et al., 2011) 
Tehran K. pneumoniae Hospital and 
Community  
 
SHV, CTX-M, 
TEM , PER   
 
(38.5) (Leila et al., 2010) 
Tehran K. pneumoniae Hospital and 
Community  
 
SHV, TEM, CTX-
M  
 
(72.1) (Feizabadi et al., 
2010) 
Tehran E. coli Hospital 
 
SHV, TEM 
 
(49) (Shahcheraghi et al.,  
2009) 
Tehran E. coli Community  
 
TEM, SHV  
 
(2.7) (Hosseini et al., 
2007) 
Tehran K.spp Hospital 
 
SHV, TEM, CTX-
M  
 
(51.6) (Ghafourian et al., 
2010) 
Tehran K. pneumoniae Hospital and 
Community  
 
SHV, TEM, CTX-
M  
 
(27.45) (Eftekhar  et al., 
2012) 
Tehran K. pneumoniae Hospital  
 
SHV, TEM-1, 
CTX-M-15   
  
(62.85) (Ashayeri  et al., 
2014) 
Tehran E. coli Hospital  
 
TEM  (64) (Yazdi  et al., 2013) 
Tehran E. coli Hospital 
 
CTX-M-1 (70) (Peerayeh et al., 
2013) 
Tehran E. coli Hospital  CTX-M, TEM, 
SHV 
(20) (Abdi,  2014) 
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Tehran P.aeruginosa Hospital  
 
TEM, PER-1  (39.2) (Rafiee et al., 2014) 
Tehran P.aeruginosa Hospital (children) 
 
AmpC (Not found 
PER) 
(83.3) (Fazeli et al., 2014) 
Tehran K. pneumoniae Hospital and 
Community 
 
CTX-M-15, OXA-
48  
(57.5) (Hashemi  et al., 
2014) 
Tehran K. pneumoniae Hospital 
 
OXA-48 (first 
report) 
   
not specified (Azimi et al., 2014) 
Tehran Shigella Hospital 
 
CTX-M-15, CMY-
1  
 
not specified (Tajbakhsh et al., 
2012) 
Tehran Gram negative 
bacil 
Hospital 
 
CTXM  
 
(29.09) (Vali et al., 2014) 
Tehran P.aeruginosa 
A. baumannii 
Hospital 
  
CTX-M-15 P (31.91) 
A (21.42) 
(Hallajzadeh  et al., 
2014) 
Tehran A. baumannii Hospital 
 
PER-1, VEB-1 
 
(84.2) (Fallah et al., 2014) 
Tehran Acineto.spp Hospital 
 
TEM, SHV  (51) (Sharif  et al., 2014) 
Tehran E. coli Hospital and 
Community 
 
TEM, CTX-M  
 
not specified (Goudarzi,  2014) 
Tehran E. coli Hospital 
 
SHV  (89.8) (Dallal et al., 2013) 
Esfahan K. pneumoniae 
E. coli 
Hospital and 
Community 
 
TEM, SHV  
 
(18.75) (Gholipour et al., 
2014) 
Esfahan P.aeruginosa Hospital 
 
GES-2, SHV-5, 
CTX –M-1  
 
(8.1) (Tavajjohi et al., 
2011) 
Esfahan P.aeruginosa Hospital 
 
OXA-10  not specified (Golshani and 
Sharifzadeh 2013) 
Markazi 
 
Qazvin 
 
Enterobacteriac
eae 
 
E. cloacae 
Hospital and 
Community 
 
Hospital 
 
CTX-M-1, CTX-
M-2,  CTX-M-8, 
CTX-M-9    
Not analyzed 
(44) 
 
(55.7) 
(Safari et al., 2013) 
 
(Peymani et al., 
2014) 
Zanjan E. coli (EAEC) Hospital and 
Community 
 
TEM, CTX-M  
 
(52.7) (Khoshvaght et al., 
2014) 
Semnan E. coli 
K. pneumoniae 
Community 
 
Not analyzed (18.1) (Moghadas, 2009) 
Eastern part of Iran  
Khorasan E. coli Hospital 
 
CTX-M,TEM, 
SHV  
 
(33.3) (Moghaddam et al., 
2012) 
Khorasan E. coli 
Klebsiella 
Hospital and 
Community 
  
SHV,TEM  (35.6) (Zaniani et al., 2012) 
 
Khorasan Enterobacteriac
eae 
Hospital and 
Community 
 
CTX-M-15 
 
not specified (Moghaddam et al., 
2014) 
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Southern part of Iran 
 
Southern part of Iran has a warm and dry weather. This region mostly includes provinces around the Persian Gulf 
and the Gulf of Oman. In Kerman Province, in the burn ward of Shafa Hospital during January 2006 to December 2007, 41 
(34%) isolated P.aeruginosa were reported to be ESBL producers; however, none of the isolates could produce any MBL 
enzyme and all ESBL-producing isolate were multidrug resistant (MDR). According to the PCR and multiplex PCR assays, 
the most prevalent genes among ESBL producers in the recent study were SHV and PER-1; but, no Amp-C gene was 
detected in any of the isolates (Shakibaie et al., 2008). 
Another study in the burn ward of Kerman University showed that the ESBL-producing P.aeruginosa was the 
same as the previous study. However, the frequency of PER-1 gene was very high and molecular results showed that 
blaVEB-1 in the P.aeruginosa strains harbor (643bp) was the most frequent ESBL gene. These data were in line with other 
results in the Middle East and Iran (Shakibaie et al., 2008). Surveys on the isolation of MDR non-fermenting GNB of the 
patients from three hospitals in Kerman indicated that all of the isolates were resistant to cefoxitin, and ESBL production 
was higher in A. baumannii than other tested bacterial species; but, the difference was not significant. A study from 
November 2007 to July 2008 on the patients admitted to hospitals in the Kerman showed that, among K. pneumoniae 
isolates, 44% produced ESBLs and 28% had AmpC (Mansouri et al., 2014). Also, among E. coli isolates, 43.7% isolates 
had ESBLs and 39.3% produced AmpC. Co-existence of ESBLs and AmpC β-lactamases was observed in 39.3% of 
Sistan 
baluchestan 
K. pneumoniae 
P.aeruginosa 
Hospital 
 
TEM, CTX-M       K (66.6) 
P (13.3) 
(Saeidi et al., 2014) 
 
Sistan 
baluchestan 
P.aeruginosa Hospital 
 
TEM, VEB-1, 
PER-1, SHV 
(6.89) (Bokaeian et al., 
2015) 
      
Western part of  Iran  
Hamedan P.aeruginosa Hospital 
 
PER-1, VEB (58.3) (Alikhani et al., 
2014) 
Hamedan A. baumannii Hospital 
 
TEM, SHV  
 
(7) (Safari et al., 2015) 
Ilam K.oxytoca Hospital  
 
Not analyzed (25) (Ghafouryan et al., 
2010) 
Kermanshah E. coli Community 
 
Not analyzed (24.5) (Mohajeri et al., 
2014) 
Kurdistan Gram negative 
bacil 
Community 
 
TEM, CTX-M, 
SHV  
(12.66) (Ramazanzadeh et 
al., 2010) 
Kurdistan Gram negative 
bacil 
Community 
 
CTX- M, TEM, 
SHV  
(14.5) (Ramazanzadeh, 
2010) 
Kurdistan P.aeruginosa Hospital 
 
PER-1, OXA-10  (28) (Kalantar et al., 2012) 
Kurdistan P.aeruginosa Hospital 
 
SHV  (17.89) (Bahmani and 
Ramazanzadeh 2013) 
East Azerbaijan K. pneumoniae Hospital 
 
SHV, TEM, CTX- 
M  
 
(43.7) (Ghafourian et al., 
2011) 
East Azerbaijan A. baumannii Hospital 
 
PER-1, VEB-1  
 
(70) (Farajnia et al., 2013) 
East Azerbaijan P.aeruginosa Hospital 
 
PER-1  (75.86) (Akhi et al., 2012) 
Ardebil Enterobacteriac
eae 
Hospital and 
Community 
 
Not analyzed (36.75) (Akbari et al., 2014) 
West Azerbaijan E. coli Hospital 
 
CTX-M-15 (41.98) (Parsania and 
Sohrabpour 2104) 
Lorestan Gram negative 
bacilli 
Hospital 
 
Not analyzed (23.6) (Zadegan et al., 2009) 
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isolates. In this study, the prevalence rate of blaCTX-M gene among ESBLs- and AmpC-producing isolates of K. pneumoniae 
and E. coli was 21.3% and 13.3%, respectively (Mansouri et al., 2014).  
Khuzestan is another province in the southern part of Iran. In an 11-month study from August 2011 to July 2012, 
500 Enterobacteriaceae isolates were collected from Ahvaz and the prevalence rates of CTX-M-1 genes among ESBLs-
positive isolates K. pneumonia were found in 26.92% (Khosravi et al., 2013). In Ganjavian Hospital, Dezful, Khuzestan 
Province, among 128 ESBL-producing Enterobacteriaceae isolates, 73 (57%) were positive for TEM and/or SHV by 
multiplex PCR. Also, 14 isolates (19%) had both blaTEM and blaSHV genes; but, blaCTX-M was not detected in ESBL-
producing strains (Moosavian and Deiham 2012).  
Analysis of P. aeruginosa isolates from the burn ward of a hospital in Khuzestan showed that 176 (95.13%) 
isolates were MDR, and the prevalence of ESBL was higher than that of a similar study in Yazd Province (Farshadzadeh et 
al., 2014). During the study period between 2009 and 2010 in Fars Province, K. pneumoniae was collected from Intensive 
Care Units (ICUs) of Namazi Hospital in Shiraz and high prevalence (60%) of ESBL-producing K. pneumonia were 
demonstrated. In addition, this study showed a new pattern of blaTEM distribution, in which blaTEM was found to be 
predominant, followed by blaCTX-M and blaSHV, respectively (Ghasemi et al., 2013). Several Iranian studies have had a 
similar pattern of ESBLs distribution, such as in Tehran Province (Nasehi et al., 2010). However, this pattern is different 
from other countries (e.g., Italy, Egypt and Austria) in which CTX-M is the most prevalent β- lactamases (Ahmed et al., 
2009). In another study at Namazi Hospital during a 2 year period, 39 Serratia strains were isolated from blood samples; 
overall, positive ESBL phenotype was identified in 69% (n=27) of the isolates: 70.37% (n=19) for of S. marcescens and 
29.62% (n=8) for S.liquefaciens and TEM gene was detected in none of the isolates in this study (Mostatabi et al., 2013). In 
previous studies from Taiwan and Mexico, it has been reported that blaSHV and blaCTX-M-3 are identified as the most 
common ESBL genes in Serratia (mostly in S.marcescens) (Cheng et al., 2006). A research on patients with diarrhea 
conducted in Shiraz among 2010 revealed that the prevalence of ESBLs-producer E. coli isolates was 12.96% (Ghorbani-
Dalini et al., 2015). Antimicrobial resistance testing showed a high resistance to cefexime, trimethoprim-sulfamethoxazole, 
ampicillin and penicillin. In their study, β-lactamase genes were identified in 96.30% isolates which were identified as 
83.33% blaTEM, 31.48% blaSHV and 20.37% blaCTX-M. In addition, this study indicated that the blaTEM gene for ESBLs-
producer E. coli isolates was widespread in Iran (Ghorbani-Dalini et al., 2015). 
Generally, in the southern part of Iran, classes A and D are more common in various samples from the provinces 
and AmpC is also present in one study. The prevalence of ESBL was between 11.75% and 69% in both hospitals and 
communities and, on average, it was 42.2%. In addition, the prevalence of ESBL in the community samples was less than 
in the hospitals (Table-1). 
 
Central part of Iran 
 
Central part of Iran consists of area between Alborz Mountains, Zagros Mountains and the scattered mountains of 
Khorasan in the east. It includes some provinces that are shown in Table-1. Most of the region has a warm and dry weather 
with the milder climate in the mountain areas. Tehran, the capital city of Iran, is the largest city of the country and also the 
largest city in Western Asia. Several surveys have been performed in this area. Analysis of K. pneumoniae isolates in the 
central parts showed that the rate of ESBL producers was between18.1% and 72% among the sample hospitals and 
communities. The ESBL-producing K. pneumoniae in the community's samples was less than that in the hospitals. 
However, samples from Tehran Hospital were more than other provinces, mostly carrying blaSHV, blaCTX-M, and blaTEM 
genes predominantly, among which the prevalence of blaSHV was higher than others (26%-77%). An investigation from 
Motahari and Shariati hospitals revealed that the rates of drug resistance in burn isolates of K. pneumoniae were higher 
compared to the non-burn strains, while no significant differences were observed in ESBL production between the two 
groups (Eftekhar and Naseh 2015). In the burn ward of Motahari Hospital, Tehran, in 2011, the first cases of OXA-48-
producing K. pneumoniae in Iran were reported and blaOXA-48 gene was detected in96.42% (27/28) of isolates by PCR 
analysis followed by sequencing (Azimi et al., 2014). Another study in Tehran from October 2011 to May 2012 reported 
that 83 non-duplicate and non-consecutive K. pneumoniae blaOXA-48 genes were found in two (4.1%) out of the 48 ESBL-
producing isolates and 2 isolates harbored both blaOXA-48 and blaCTX-M-15 (Hashemi et al., 2014). Reports of blaOXA-48 have 
been dramatically increased in recent years worldwide and OXA-48-producing K. pneumoniae and other isolates have been 
reported from various regions such as Turkey, Morocco, Lebanon, Belgium, United Kingdom, Tunisia, Argentina, and 
India (Cuzon et al., 2011). 
A study demonstrates the predominant presence of the gene encoding CTX-M-1 group among ESBLs producing 
of Salmonella spp. that they can transmit to bacteria of this genus or even other genera of enteric bacteria (Rizi et al., 2015). 
In the recent study, four Salmonella spp. (3.6%) showed ESBLs phenotype, which all have blaCTX-1 genes group. ESBL-
producing E.coli in the central part of Iran has different ranges between hospitals and the community. According to the 
data, the majority of ESBL-producing isolates were from hospital patients in Tehran. Substantial proportions of E. coli 
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reported from urine samples in the central part of Iran and rate of ESBL-producing E.coli between hospitals in this region 
were 28%-89.8%, which was higher than that of the communities. Also, CTX-M and TEM type ESBLs appear to be 
predominating among ESBL-producing E.coli in the region (Pakzad et al., 2011). A study about E.coli isolated from urine 
samples from patients with urinary tract infection (UTI) referred to two main hospitals in Tehran, during September 2010 to 
March2011, showed that 20% of E. coli isolates were ESBL-producer and frequency of blaCTX-M, blaTEM, and blaSHV genes 
was 87%, 82%, and 65%, respectively (Abdi et al., 2014). In a similar study from a Children Medical Center in Tehran 
between 2012 and 2013, the presence of blaCTX-M and blaTEM were detected in 69 (69%) and 74 (74%) of isolates, 
respectively, while blaSHV gene was absent (Goudarzi et al., 2013). 
Notably, in the other province in the central part of Iran in isolates of Enterobacteriaceae from Markazi province, 
the frequency of CTX-M-1,-2,-8,-9 among the isolates were as 92.2%, 28.5%, 17.5%, and 38.3%, respectively (Safari et al., 
2013). This value was different from other studies in other countries. For example, studies in Sudan, Korea, and Thailand 
have demonstrated that the prevalence of CTX-M-1 was 45.9%, 16.4%, and14%, respectively (Safari et al., 2013). 
However, the prevalence of CTX-M-9 in Germany, America, and Canada is in the range of 38.5%-58.5% (Safari et al., 
2013). Nevertheless, other studies have shown that the dissemination of CTX-M-8 gene in Iran is higher compared to the 
rest of the world (Kim et al., 2008). Analysis of non-fermenting GNB in the central part of Iran showed that the lowest 
ESBL-producing was 8.1% in Isfahan Province and the highest was 83.3% in hospitals of Tehran Province (Kim et al., 
2008; Fazeli et al., 2015). 
In a study from Tehran, 51 non-duplicate P. aeruginosa isolates were randomly selected from a collection of burn 
isolates of a hospital in 2011 and it was found that 43 isolates (84.3%) carried β-lactamase genes, out of which 31 (60.8%) 
harbored blaAmpC, 20 (39.2%) isolates had blaTEM, and 11 (21.6%) carried blaPER-1 genes (Rafiee et al., 2014). But, in 
another study, during a 3 month period, from November 2011 to January 2012, 72 clinical isolates of P. aeruginosa 
collected from the samples included blood specimen, urine, wound, tracheal, throat, and other samples from a major 
pediatric hospital in Tehran reported that none of them had bla PER, bla BEL, and all of the isolates had ampC gene (Fazeli et 
al., 2015). This study was the first work among the samples from children in which PER was not detected (Fazeli et al., 
2015). 
Other provinces in the central part of the country have also reported non-fermenting ESBL-producing GNB. In a 
study from Beheshti Hospital in Kashan that was conducted during 2010 to 2011, it was reported that, from 86 urine, 
trachea, and stool samples, 19 (20.9%) P. aeruginosa isolates were resistant to all extended-spectrum cephalosporins 
(Tavajjohi et al., 2011). This study also reported 8.1% ESBL-production among P. aeruginosa isolates and the blaGES-2 
gene was detected in all ESBL-producing P. aeruginosa. GES-2 in the same study was different from other results in the 
Middle East region and Iran (Tavajjohi et al., 2011). It was reported from Kashan that the prevalence of blaCTX-M among 
Enterobacteriacea isolates was at an alarming rate (Hasan Afzali et al., 2015). It the recent study that conducted in 2013, 
from 100 Klebsiella spp. isolates, 41% of isolates had resistance ceftazidime or aztreonam and 35% were ESBLproducers, 
which 80% of the resistant isolates carried the blaCTX-M type genes. Moreover, CTX-M-1, CTX-M-2 and CTX-M-9 were 
identified in 60%, 42% and 34% of these isolates, respectively (Hasan Afzali et al., 2015). In another research from 
Kashan, 47% of ESBL-producing isolates were identified by DDST confirmatory test and majority (80.5%) of isolates 
carried 𝑏𝑙𝑎CTX-M genes including CTX-M-1 (60%), CTX-M-2 (42.9%), and CTX-M-9 (34.3%) (SHAMS et al., 2015). 
Also, 77 ESBL-producing K. pneumoniae were positive with PMQR genes, which mostly consisted of aac(6´)-Ib-cr 
(70.1%) and qnrB (46.0%), followed by qnrS (5.7%). Among these PMQR positive isolates, 35.1% and 1.3% of isolates 
carried 2 and 3 different PMQR genes, respectively (Shams et al., 2015).  Frequency of blaOXA-10 in ESBL-producing P. 
aeruginosa was 40 (64%) in another study from Isfahan in 2012 (Golshani and Sharifzadeh, 2013). In a study on P. 
aeruginosa clinical isolates, 76 isolates were collected from Milad hospital in Tehran (Akbariqomi et al., 2015). In their 
study, 76.3% of isolates classified as MDR and The majority of them were found in ESBL producer P. aeruginosa. Also, 
the effective antibiotics against ESBL and non-ESBL were meropenem and amikacin, respectively. In the central region of 
the country, only in the hospitals of Tehran, ESBL-producing Acinetobacters were between 21.4% and 84.2% in three 
studies. The rate of PER-1, VEB-1, CTX-M-15, TEM, and SHV was 78.03%, 39.5%, 9.3%, 56%, and 63%, respectively 
(Hakemi et al., 2014; Sharif et al., 2014). 
Another study that was conducted in a major pediatric hospital in Tehran showed that 4 out of 55 Shigella isolates, 
including three S. sonnei and one S. flexneri, had ESBL-positive phenotype (Tajbakhsh et al., 2012). Also one S. sonnei 
isolate had CMY-59 gene. The ESBL-producing Shigella isolates in this study were higher than previous studies in other 
countries (Tajbakhsh et al., 2012). Therefore, the prevalence of ESBL-producing GNB in the central part of Iran was 
between 2.3% and 89.8% and the average prevalence of ESBL-producing GNB in the central part of Iran was 43.55% in 
hospitals and community samples. Also, class A and D β-lactamases were the most prevalent in the region (Table 1). 
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Eastern part of Iran 
 
This part of Iran has a warm and dry weather and is near Afghanistan and Pakistan borderlines. In this area, ESBL-
producing GNB was reported in Khorasan as well as Sistan and Baluchestan Provinces. Analysis of E. coli isolates from 
urine samples of hospitalized patients was collected in 2009 at two hospitals in Mashhad city, which showed that 33.3% 
were ESBL producers and carrying blaCTX in 94.6%, blaTEM in 56.8%, and blaSHV in 13.5% of the isolates (Moghaddam et 
al., 2012). In this study, blaCTX-M was found to be higher than the developed countries and other studies in Iran 
(Moghaddam et al., 2012). To determine the frequency of qnr genes in isolates from Imam Reza hospital in Mashhad, 200 
clinical isolate of E. coli were investigated (Mood et al., 2015). Results indicated that 43% of isolates were ciprofloxacin-
resistant. Also, the phenotypic confirmatory test identified 42.5% isolates as ESBL-producing. Isolates were positive for 
blaTEM in 76.47%, blaSHV in 27%, qnrA in 31%, qnrB in 17%, and qnrS in 7%. In another research that was carried out in 
2010, 82 E. coli and 78 K. pneumoniae were isolated from different clinical samples. In their study, 43.9% of E. coli and 
56.1% of K. pneumoniae were ESBL producer, which in the community was lower than the hospital samples and 
frequencies of SHV and TEM were 14.4% and 20.6%, respectively (Riyahi et al., 2012). Recently, a survey conducted on 
Enterobacteriaceae isolates from urine samples on inpatients and outpatients who referred to Qaem and 17-Shahrivar 
Hospitals in Mashhad city in 2012. It was found that 27 (27%) isolates were ESBL-producing organisms with the highest 
frequency for K. pneumonia (47.4%) and E. coli (17.9%). Also, 26 (26%) Enterobacteriaceae isolates harbored the blaCTX-M 
gene. It was the first report of blaCTX-M-15 among E. coli isolates in this region. No blaPER was found among the isolates, 
which was similar to the work conducted by Shahcheraghi et al. in Tehran (Moghaddam et al., 2014). 
To evaluate 180 isolates including 30 K. pneumoniae and 150 P. aeruginosa, a study was performed on the urine 
samples of hospitalized patients in a hospital of Zabol city in Sistan and Baluchestan Province (74). In this work, the 
prevalence of ESBL-producing isolates was13.3% for P. aeruginosa and 66.6% for K. pneumonia. Also, 75% and 65% of 
K. pneumoniae harbored the TEM and CTX-M genes, respectively, and 55% of P. aeruginosa isolates harbored the gene 
TEM; but, none of them demonstrated CTX-M gene. This prevalence of ESBLs-producing organisms was higher than that 
of other studies (Saeidi et al., 2014). Another study was conducted on non-fermentative GNB isolates during 2012–2013 on 
116 P. aeruginosa isolates from Zahedan city, 6.89% isolates were ESBL-positive. Among them, 100% had blaTEM, 13.3% 
had blaPER-1, 6.6% had blaVEB-1 and 6.6% had blaSHV. blaTEM gene in this study had 100% identity with blaTEM-116 (Bokaeian 
et al., 2015). In characterization of ESBL and AmpC producers among E. coli from three major hospitals in Zahedan, 
almost half of isolates were resistant to third generation of cephalosporins; of these 62.7% and 5% were ESBL and AmpC 
producers, respectively. Molecular analysis showed that 49.1% and 5% were positive for blaTEM and blaCMY2, respectively 
(Shayan and Bokaeian, 2015). 
Overall, in this part of Iran, the prevalence of ESBL-producing GNB ranged between 6.89% and 66.6%, the 
average of which was 31.13%. Among ESBL-producing GNB in this region, class A β-lactamase was the most prevalent 
one (Table 1). 
 
Western part of Iran 
 
This part of the country with several cities has a cold and rainy weather and is bordered with Turkey and Iraq. The 
prevalence of ESBL-producing isolates in this region has been also studied and in some provinces and cities. During a 7-
month study in 2009, out of 106 isolates of P. aeruginosa from two tertiary hospitals in Hamadan, 88.7% of the isolates 
were MDR and 58.25% were ESBL producer (Alikhani et al., 2014). Also, among 60 ESBL-producing strains, 16 (26.6%), 
9(15%), and 3(5%) strains had blaPER-1, blaVEB-1, blaPER-1, and blaVEB related genes, respectively (Alikhani et al., 2014). The 
rates of blaVEB and blaPER ESBLs were the same as other studies in Tehran (SHAHCHERAGHI et al., 2009); however, it 
was higher than those of Turkey and Korea and lower than Thailand and Italy (Shahcheraghi et al., 2009). In another 
survey, 100 A. baumannii strains were isolated from ICU wards of three educational hospitals in Hamadan (Safari et al., 
2015). This study was conducted in 2011 and reported that 7% of isolates were ESBLs producers; this rate was very lower 
than that of other Iranian studies. Among all the isolates, 58%, and 20% were harboring SHV and CTXM genes, 
respectively (Safari et al., 2015). 
  Kurdistan is another province located in the west of the country. Studies have shown that the rate of ESBL-
producing strains in communities is lower than hospitals. For example, out of158 GNB isolated from the outpatients 
referring to hospital in Sanandaj, 20 (12.66%) isolates were ESBL producer and the majority of community acquired ESBL 
types belonging to CTX-M and SHV were 10.76% and TEM was 9.49% (Ramazanzadeh et al., 2010). In another study 
from Kurdistan that was conducted on 188 urinary tract infection outpatients in 2008, it was revealed that 27 (14.5%) 
isolates were ESBL-producing GNB and CTX-M type was the most prevalent one (12.7%). Also, the prevalence of SHV, 
TEM was 11.7% and 10.1%, respectively (Ramazanzadeh et al., 2010). The analysis of P. aeruginosa isolates from the 
patients who were hospitalized in Sanandaj showed that 17.89% of the isolates were ESBL producer and the prevalence of 
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blaSHV was 10.57%; this rate was lower than that of other Iranian studies (Bahmani and Ramazanzadeh, 2013). Another 
work on the burn patients of Tohid Hospital in Kurdistan showed that, out of 100 P. aeroginusa isolates, 28% were positive 
for ESBL production and 48% and 52% had PER-1 and OXA-10 producers, respectively (Kalantar et al., 2012). 
East Azerbaijan and West Azerbaijan are other provinces in this part of the country which have the highest 
prevalence of β-lactamases. The prevalence of ESBLs rate in East Azerbaijan was reported 43.3% in a survey (Ghafourian 
et al., 2011). In a study that was conducted in 2008, blaSHV, blaTEM, and blaCTX-M were identified as 86.7%, 15.6%, and 
15.6%, respectively (Ghafourian et al., 2011). ESBLs-producing E. coli at hospitals of West Azerbaijan Province was 
relatively similar to that of the previous study (41.98%) that carried 23.63% blaCTX-M-15 gene (Parsania and Sohrabpour, 
2014). Analysis of ESBL-producing non-fermentative bacteria in East Azerbaijan showed that 70% and 75.68% of the 
isolates were A. baumannii and P.aeruginosa, respectively; this rate was the maximum in Iran. Also, analysis of ESBL 
genes in this bacteria showed that, among 100 A. baumannii isolates, 51% were positive for PER-1 and 10% positive for 
VEB1, whereas none of the isolates were positive for PER2 type gene. In this study, the prevalence of blaPER-1 among 56 P. 
aeruginosa isolates was 27.5% (Farajnia et al., 2013). In a study from the Tabriz region, K. pneumoniae isolates had the 
same ESBL prevalence as E.coli isolates (SHAMS et al., 2015). In a same study, the presence of integron class 1 was 
associated with presence of ciprofloxacin resistance in both organisms and co-presence of class 1 and 2 and the presence of 
ESBL production. However, nalidixic acid resistance was related significantly with only integron class 1 and to the 
presence of ESBL production. Class 1 and 2 integrons were found in 73.5% of MDR isolates with 13.2% of them 
possessing both intI1 and intI2 genes (Shams et al., 2015). 
The frequency of ESBL-producing GNB is reported in other provinces in this region; however, ESBL genes have 
not been analyzed. For example, in a study performed in Ilam hospitals during March 2007 to April 2008, among the 
samples taken from the wards of surgery as well as lesion and infection of the respiratory tract, 25% of K. oxytoca were 
reported to be ESBL-positive (Ghafouryan et al., 2010). In another study from Kermanshah Province, 200 isolates of 
Uropathogenic Escherichia coli (UPEC) were collected among urine samples in the community from February 2012 to 
February 2013 and 24.5% (𝑛 = 49) of isolates were found to be positive for ESBL production (Mohajeri et al., 2014). The 
prevalence of ESBL-producing GNB in the urine samples of hospitalized patients in Imam Khomeini Hospital of Ardabil 
Province in 2012 showed that, out of 400 Enterobacteriaceae, 147 (36.75%) isolates were positive for ESBL (Akbari, Amir 
Mozaffari et al., 2014). In another study from Shohada-ye Ashayer Hospital in Lorestan Province, from225 isolates, 53 
(23.6%) were positive in terms of ESBL production (Zadegan et al., 2009). 
Finally, in the western part of Iran, the prevalence of ESBL-producing GNB ranged from 7% to 75.86% in the 
samples of communities and hospitals and, on average, it was 34.26%. Also, Class A, D Ambler was the most prevalent one 
(Table 1). 
 
Conclusion 
 
Iran, like many other parts of the world, has experienced a significant increase in the numberof ESBL-producing 
GNB in the hospitals and communities. Thus, this review indicates that spread of ESBL-producing GNB is a great problem 
in healthcare centers. In the community setting, ESBL-producing GNB mostly have a lower prevalence than the hospital. 
However, it should be considered that the prevalence of ESBL genes varies in different geographical areas. The current 
rates in some parts of the country are very high, especially in the central part of Iran, such as Tehran Province. So, the 
highest rate of ESBL-producing E. coli, K. pneumonia, A. baumannii, and P.aeruginosa has been reported in the hospitals 
of Tehran in the recent years. Other parts of the country also have high prevalence of ESBL-producing GNB in both 
hospitals and communities. It is clear that ESBL-producing organisms are widely distributed globally; but, this rate is lower 
in several parts of the world than Iran. Most frequent types of ESBL enzymes in Iran include TEM, CTX-M, SHV, and 
OXA; but, there are other ESBL enzymes with different frequencies among GNB such as PER, VEB, and GES. In many 
parts of the world such as European Countries, Latin America, East and West Asia in Gulf Cooperation Council (GCC), 
and Africa, CTX-M variants become dominant β- lactamases in compare to TEM and SHV enzymes in GNB. In most 
reports, TEM, CTX-M, and SHV are the predominant and OXA-type ESBLs have been found mainly in P. aeruginosa and 
A. baumannii isolates in this region. Therefore, the presence of ESBLs genes is a risk factor for the future use of 
antimicrobial treatment in Iran. ESBLs distribution and the facilitation of their spread in different regions may be caused by 
factors such as "mobility" of ESBL genes, strong selective pressure of antibiotic use, purchase antibiotics without 
prescriptions, lack of observing hand hygiene, use of antibiotics in animals, travel, and different weather conditions. Future 
research should be focused on the areas in which no reports of ESBL have been made. Also, the areas with less prevalence 
of ESBL-producing GNBs and ESBL genes must be considered in order to take specific measures and increase supervision 
in the hospitals and the community in case any changes or increase occur in terms of prevalence. 
 
 
Leylabadlo et al., Afr., J. Infect. Dis. (2017) 11 (2): 39-53 
https://doi.org/10.21010/ajid.v11i2.6  
 
49 
 
Acknowledgements 
 
This study was supported by Drug Applied Research Centre and the authors thank all staff of Microbiology 
laboratory for their collaborations and help. 
 
Source of support: This study was supported by Drug Applied Research Center, Tabriz University of Medical Sciences, 
Tabriz, Iran  
 
References 
 
1. Abdi, S., Ranjbar, R., Vala, M. H., Jonaidi, N., Bejestany, O. B., and Bejestany, F. B. (2014). Frequency of bla TEM, 
bla SHV, bla CTX-M, and qnrA Among Escherichia coli Isolated From Urinary Tract Infection. Archives of Clinical 
Infectious Diseases; 9(1).  
2. Ahanjan, M., Kholdi, S., and Rafiei, A. (2014). Antibiotic-resistance Patterns and Frequency of TEM and CTX Type 
Extended-spectrum β-lactamases in Acinetobacter Clinical Isolates. Journal of Mazandaran University of Medical 
Sciences; 24(116), 32-40. 
3. Ahmed, S. H., Daef, E. A., Badary, M. S., Mahmoud, M. A., and Abd-Elsayed, A. A. (2009). Nosocomial blood stream 
infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended 
spectrum β-lactamase producing organisms. BMC Research Notes;  2(1), 76.  
4. Akbari, M., Amir Mozaffari, N., and Peeri Dogaheh, H. (2014). Prevalence of Extended-Spectrum Beta Lactamase in 
Entrobacteriaceae Isolated from Urinary Tract Infections in Ardabil, Iran. Journal of Ardabil University of Medical 
Sciences; 14(3), 285-291. 
5. Akbariqomi, M., Ghafourian, S., Taherikalani, M., Mohammadi, S., Pakzad, I., and Sadeghifard, N. (2015). Antibiotic 
Susceptibility Patterns of Extended Spectrum Beta-Lactamase and Non Extended Spectrum Beta-Lactamase 
Pseudomonas aeruginosa Clinical Isolates. Recent patents on anti-infective drug discovery; 10(2), 128-133. 
6. Akhi, M. T., Khalili, Y., Ghottaslou, R., and Aghazadeh, M. (2012). Prevalence of PER-1-type extended-spectrum 
beta-lactamaes in clinical strains of Pseudomonas aeruginosa isolated from Tabriz, Iran. Iranian journal of basic 
medical sciences; 15(1), 678. 
7. Alikhani, M. Y., Tabar, Z. K., Mihani, F., Kalantar, E., Karami, P., Sadeghi, M., and Farajnia, S. (2014). Antimicrobial 
resistance patterns and prevalence of blaPER-1 and blaVEB-1 genes among ESBL-producing Pseudomonas aeruginosa 
isolates in West of Iran. Jundishapur Journal of Microbiology; 7(1). 
8. Ananthan, S., and Subha, A. (2005). Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella 
pneumoniae and Escherichia coli. Indian journal of medical microbiology; 23(1), 20. 
9. Ashayeri-Panah, M., Feizabadi, M., and Eftekhar, F. (2014). Correlation of multi-drug resistance, integron and 
blaESBL gene carriage with genetic fingerprints of extended-spectrum β-lactamase producing Klebsiella pneumoniae. 
Jundishapur Journal of Microbiology; 7(2). 
10. Azimi, L., Nordmann, P., Lari, A. R., and Bonnin, R. A. (2014). First report of OXA-48-producing Klebsiella 
pneumoniae strains in Iran. GMS Hygiene & Infection Control; 9(1). 
11. Bahmani, N. and R. Ramazanzadeh (2013). Detection of SHV type extended-spectrum B-lactamase and risk factors in 
pseudomonas aeruginosa clinical isolates.  Pakistan journal of medical sciences; 29(3): 788. 
12. Bokaeian, M., Zahedani, S. S., Bajgiran, M. S., and Moghaddam, A. A. (2015). Frequency of PER, VEB, SHV, TEM 
and CTX-M Genes in Resistant Strains of Pseudomonas aeruginosa Producing Extended Spectrum β-
Lactamases. Jundishapur journal of microbiology; 8(1). 
13. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and 
detection of this important resistance threat. Clinical microbiology reviews; 14(4), 933-951. 
14. Bush, K., and Mobashery, S. (1998). How β-lactamases have driven pharmaceutical drug discovery. In Resolving the 
Antibiotic Paradox (pp. 71-98). Springer US. 
15. Cheng, K., Chuang, Y., Wu, L., Huang, G., and Yu, W. (2006). Clinical experiences of the infections caused by 
extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan. Japanese journal of 
infectious diseases; 59(3), 147. 
16. Cuzon, G., Ouanich, J., Gondret, R., Naas, T., and Nordmann, P. (2011). Outbreak of OXA-48-positive carbapenem-
resistant Klebsiella pneumoniae isolates in France. Antimicrobial agents and chemotherapy; 55(5), 2420-2423. 
17. Dallal, M. S., Sabbaghi, A., Aghamirzaeie, H. M., Lari, A. R., Eshraghian, M. R., Mehrabad, J. F., and Rajabi, Z. 
(2013). Prevalence of AmpC and SHV β-lactamases in clinical isolates of Escherichia coli from Tehran 
Hospitals. Jundishapur Journal of Microbiology; 6(2), 176-180. 
Leylabadlo et al., Afr., J. Infect. Dis. (2017) 11 (2): 39-53 
https://doi.org/10.21010/ajid.v11i2.6  
 
50 
 
18. Eftekhar, F., and Naseh, Z. (2015). Extended-spectrum β-lactamase and carbapenemase production among burn and 
non-burn clinical isolates of Klebsiella pneumoniae. Iranian journal of microbiology; 7(3), 144.  
19. Eftekhar, F., Rastegar, M., Golalipoor, M., and Mansoursamaei, N. (2012).  Detection of Extended Spectrum B-
Lactamases in Urinary Isolates of Klebsiella pneumoniae in Relation to blaSHV, blaTEM and blaCTX-M gene 
carriage. Iranian journal of public health; 41(3), 127. 
20. Fallah, F., Noori, M., Hashemi, A., Goudarzi, H., Karimi, A., Erfanimanesh, S., and Alimehr, S. (2014). Prevalence of 
blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of 
Tehran, Iran. Scientifica; 2014. 
21. Farajnia, S., Azhari, F., Alikhani, M. Y., Hosseini, M. K., Peymani, A., and Sohrabi, N. (2013). Prevalence of PER and 
VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in North-
West of Iran. Iranian journal of basic medical sciences; 16(6), 751-755. 
22. Farshadzadeh, Z., Khosravi, A. D., Alavi, S. M., Parhizgari, N., and Hoveizavi, H. (2014). Spread of extended-
spectrum β-lactamase genes of bla OXA-10, bla PER-1 and bla CTX-M in Pseudomonas aeruginosa strains isolated 
from burn patients. Burns; 40(8), 1575-1580. 
23. Fazeli, H., Sadighian, H., Nasr-Esfahani, B., and Pourmand, M. (2015). Identification of class-1 integron and various 
β-lactamase classes among clinical isolates of Pseudomonas aeruginosa at children's medical center hospital. Journal of 
Medical Bacteriology; 1(3-4), 25-36. 
24. Feizabadi, M. M., Mahamadi-Yeganeh, S., Mirsalehian, A., Mirafshar, S. M., Mahboobi, M., Nili, F., and Yadegarinia, 
D. (2010). Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. The 
Journal of Infection in Developing Countries; 4(10), 609-615.  
25. Ghafourian, S., Sadeghifard, N., bin Sekawi, Z., Neela, V. K., Shamsudin, M. N., Mohebi, R., and Raftari, M. (2010). 
Antimicrobial pattern and clonal dissemination of extended-spectrum beta-lactamase producing Klebsiella Spp 
isolates. American Journal of Infectious Diseases; 6(4), 110. 
26. Ghafourian, S., Sadeghifard, N., Sekawi, Z., Neela, V. K., Shamsudin, M. N., Pakzad, I., and Rahbar, M. (2011). 
Phenotypic and genotypic assay for detection of extended spectrum B-lactamases production by Klebsiella pnemoniae 
isolates in Emam Reza Hospital in Tabriz, Iran. Journal of Pure and Applied Microbiology; 5(1), 1-10. 
27. Ghafouryan, S., Sadeghifard, N., Neela, V., Mariana, N. S., Mohebi, R., Rahbar, M., and Pakzad, I. (2010). Occurrence 
of Klebsiella oxytoca producing extended-spectrum beta-lactamases in different seasons in Ilam Hospitals, 
Iran. African Journal of Microbiology Research; 4(22), 2381-2387. 
28. Ghasemi, Y., Archin, T., Kargar, M., and Mohkam, M. (2013). A simple multiplex PCR for assessing prevalence of 
extended-spectrum B-lactamases producing Klebsiella pneumoniae in Intensive Care Units of a referral hospital in 
Shiraz, Iran. Asian Pacific Journal of Tropical Medicine; 703-708. 
29. Gholipour, A., Soleimani, N., Shokri, D., Mobasherizadeh, S., Kardi, M., and Baradaran, A. (2014). Phenotypic and 
molecular characterization of extended-Spectrum β-lactamase produced by Escherichia coli, and Klebsiella 
pneumoniae isolates in an educational hospital. Jundishapur journal of microbiology; 7(10). 
30. Ghorbani-Dalini, S., Kargar, M., Doosti, A., Abbasi, P., and Sarshar, M. (2015). Molecular Epidemiology of ESBL 
Genes and Multi-Drug Resistance in Diarrheagenic Escherichia coli strains Isolated from Adults in Iran. Iranian journal 
of pharmaceutical research: IJPR; 14(4), 1257. 
31. Giamarellou, H. (2005). Multidrug resistance in Gram-negative bacteria that produce extended-spectrum β-lactamases 
(ESBLs). Clinical Microbiology and infection; 11, 1-16. 
32. Golshani, Z., and Sharifzadeh, A. (2013). Prevalence of blaOxa10 Type Beta-lactamase Gene in Carbapenemase 
Producing Pseudomonas aeruginosa Strains Isolated From Patients in Isfahan. Jundishapur Journal of 
Microbiology; 6(5). 
33. Goudarzi, H., Aghamohammad, S., Hashemi, A., Nikmanesh, B., and Noori, M. (2013). Distribution of bla TEM, bla 
SHV and bla CTX-M genes among Escherichia coli isolates causing urinary tract infection in children. Archives of 
Clinical Infectious Diseases; 8(3).  
34. Hakemi Vala, M., Hallajzadeh, M., Hashemi, A., Goudarzi, H., Tarhani, M., Sattarzadeh Tabrizi, M., and Bazmi, F. 
(2014). Detection of Ambler class A, B and D ß-lactamases among Pseudomonas aeruginosa and Acinetobacter 
baumannii clinical isolates from burn patients. Ann Burns Fire Disasters; 27(1), 8-13. 
35. Hasan Afzali, F. F., Amiri, A., Moniri, R., and Zibaei, M. (2015). Characterization of CTX-M-Type Extend-Spectrum 
β-Lactamase Producing Klebsiella spp. in Kashan, Iran. Jundishapur journal of microbiology; 8(10). 
36. Hashemi, A., Fallah, F., Erfanimanesh, S., Hamedani, P., Alimehr, S., and Goudarzi, H. (2014). Detection of β-
lactamases and outer membrane porins among Klebsiella pneumoniae strains isolated in Iran. Scientifica; 2014(6). 
37. Hemmati, T. B., Mehdipour Moghaddam, M. J., Salehi, Z., and Habibzadeh, S. M. (2015). Prevalence of CTX-M-Type 
β-Lactamases in Multi-Drug Resistant Escherichia coli Isolates from North of Iran, Rasht. Biological Journal of 
Microorganism; 3(12).  
Leylabadlo et al., Afr., J. Infect. Dis. (2017) 11 (2): 39-53 
https://doi.org/10.21010/ajid.v11i2.6  
 
51 
 
38. Hosseini-Mazinani, S. M., Eftekhar, F., Milani, M., and Ghandili, S. (2007). Characterization of β-Lactamases from 
Urinary Isolates of Escherichia coli in Tehran. Iranian Biomedical Journal; 11(2), 95-99. 
39. Jin, H., Xu, X. M., Mi, Z. H., Mou, Y., and Liu, P. (2009). Drug-resistant gene based genotyping for Acinetobacter 
bauinannii in tracing epidemiological events and for clinical treatment within nosocomial settings. Chinese Medical 
Journal (English Edition); 122(3), 301. 
40. Kalantar, E., Taherzadeh, S., Ghadimi, T., Soheili, F., Salimizand, H., and Hedayatnejad, A. (2012). Pseudomonas 
aeruginosa, an emerging pathogen among burn patients in Kurdistan Province, Iran. Southeast Asian Journal of 
Tropical Medicine and Public Health; 43(3), 712. 
41. Kargar, M., Kargar, M., Jahromi, M. Z., Najafi, A., and Ghorbani-Dalini, S. (2014). Molecular detection of ESBLs 
production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections. Indian 
Journal of Pathology and Microbiology; 57(2), 244. 
42. Khoshvaght, H., Haghi, F., and Zeighami, H. (2014). Extended spectrum betalactamase producing Enteroaggregative 
Escherichia coli from young children in Iran. Gastroenterology and Hepatology from bed to bench; 7(2), 131. 
43. Khosravi, A. D., Hoveizavi, H., and Mehdinejad, M. (2013). Prevalence of Klebsiella pneumoniae encoding genes for 
CTX-M-1, TEM-1 and SHV-1 extended-spectrum beta lactamases (ESBL) enzymes in clinical specimens. Jundishapur 
Journal of Microbiology; 6(10). 
44. Kim, J. Y., Kim, S. H., Jeon, S. M., Park, M. S., Rhie, H. G., and Lee, B. K. (2008). Resistance to fluoroquinolones by 
the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and 
Shigella sonnei strains isolated in Korea. Clinical Microbiology and Infection; 14(8), 760-765. 
45. Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff-Neutzling, R. M., and Wiedemann, B. (1985). Evolution of plasmid-
coded resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy; 28(2), 302-307. 
46. Lasehi, K., Shahcheraghi, F., Nikbin, V. S., and Nematzadeh, S. (2010). PER, CTX-M, TEM and SHV Beta-
lactamases in clinical isolates of Klebsiella pneumoniae isolated from Tehran, Iran. Iranian Journal of Basic Medical 
Sciences; 13(3), 111-118.  
47. Leylabadlo, H. E., Asgharzadeh, M., and Aghazadeh, M. (2015). Dissemination of carbapenemases producing Gram 
negative bacteria in the Middle East. Iranian journal of microbiology; 7(5), 226. 
48. Leylabadlo, H. E., Kafil, H. S., Yousefi, M., Aghazadeh, M., and Asgharzadeh, M. (2016). Persistent infection with 
metallo-beta-lactamase and extended spectrum β-lactamase producer Morganella morganii in a patient with urinary 
tract infection after kidney transplantation. Journal of Natural Science, Biology, and Medicine; 7(2), 179. 
49. Little, M. L., Qin, X., Zerr, D. M., and Weissman, S. J. (2012). Molecular diversity in mechanisms of carbapenem 
resistance in paediatric Enterobacteriaceae. International journal of antimicrobial agents; 39(1), 52-57. 
50. Mansouri, S., Neyestanaki, D. K., Shokoohi, M., Halimi, S., Beigverdi, R., Rezagholezadeh, F., and Hashemi, A. 
(2014). Characterization of AmpC, CTX-M and MBLs types of β-lactamases in clinical isolates of Klebsiella 
pneumoniae and Escherichia coli producing Extended Spectrum β-lactamases in Kerman, Iran. Jundishapur Journal of 
Microbiology; 7(2). 
51. Mansouri, S., Razavi, M., Norouzi, F., Gholamhoseinian, N. S. (2012). Prevalence of β-Lactamase Production and 
Antimicrobial Susceptibility of Multidrug Resistant Clinical Isolates of Non-Fermenting Gram Negative Bacteria From 
Hospitalized Patients in Kerman/Iran. Jundishapur J Microbiol; 5(2), 405-10. 
52. Mozhdeh, R., Fatemeh, N., and Sasan, G. N. (2012). Prevalence of β-Lactamase production and antimicrobial 
susceptibility of multidrug resistant clinical isolates of non-fermenting Gram negative bacteria from hospitalized 
patients in Kerman/Iran. Jundishapur Journal of Microbiology; 2012(2, Spring), 405-410. 
53. Moghadas, A. J., Irajian, G., and Beheshti, A. (2009). Prevalence of extended-spectrum beta lactamase positive and 
multidrug resistance pattern of Escherichia coli and Klebsiella pneumoniae isolates, Semnan, Iran. Iranian Journal of 
Microbiology; 1(1), 49-53. 
54. Moghaddam, M. J. M., Mirbagheri, A. A., Salehi, Z., and Habibzade, S. M. (2015). Prevalence of class 1 integrons and 
extended spectrum beta lactamases among multi-drug resistant Escherichia coli isolates from North of Iran. Iranian 
biomedical journal; 19(4), 233. 
55. Moghaddam, M. N., Beidokhti, M. H., Jamehdar, S. A., and Ghahraman, M. (2014). Genetic properties of blaCTX-M 
and blaPER β-lactamase genes in clinical isolates of Enterobacteriaceae by polymerase chain reaction. Iranian journal 
of basic medical sciences; 17(5), 378. 
56. Moghaddam, M. N., Forghanifard, M. M., and Moshrefi, S. (2012). Prevalence and Molecular Characterization of 
Plasmid-mediated Extended-Spectrum β-Lactamase Genes (balaTEM, blaCTX and blASHV) Among Urinary 
Escherichia coli Clinical Isolates in Mashhad, Iran. Iranian journal of basic medical sciences; 15(3), 833-839. 
57. Mohajeri, P., Darfarin, G., and Farahani, A. (2014). Genotyping of ESBL producing Uropathogenic Escherichia coli in 
west of Iran. International journal of microbiology; 2014. 
Leylabadlo et al., Afr., J. Infect. Dis. (2017) 11 (2): 39-53 
https://doi.org/10.21010/ajid.v11i2.6  
 
52 
 
58. Mood, E. H., Meshkat, Z., Izadi, N., Rezaei, M., Jamehdar, S. A., and Nasab, M. N. (2015). Prevalence of Quinolone 
Resistance Genes Among Extended-Spectrum B-Lactamase-Producing Escherichia coli in Mashhad, Iran. Jundishapur 
journal of microbiology; 8(12). 
59. Moosavian, M., and Deiham, B. (2012). Distribution of TEM, SHV and CTX-M Genes among ESBL-producing 
Enterobacteriaceae isolates in Iran. African Journal of Microbiology Research; 6(26), 5433-5439. 
60. Mostatabi, N., Farshad, S., and Ranjbar, R. (2013). Molecular evaluations of extended spectrum β-lactamase producing 
strains of Serratia isolated from blood samples of the patients in Namazi Hospital, Shiraz, Southern Iran. Iranian 
journal of microbiology; 5(4), 328. 
61. Nagdeo, N. V., Kaore, N. M., and Thombare, V. R. (2012). Phenotypic methods for detection of various β-lactamases 
in Gram-negative clinical isolates: Need of the hour. Chronicles of Young Scientists; 3(4), 292. 
62. Nasehi, L., Shahcheraghi, F., Nikbin, V. S., and Nematzadeh, S. (2010). PER, CTX-M, TEM and SHV Beta-
lactamases in clinical isolates of Klebsiella pneumoniae isolated from Tehran, Iran. Iranian Journal of Basic Medical 
Sciences; 13(3), 111-118. 
63. NasrolahiOmran, A., Javid, N., Shakeri, F., Yazdi, M., and Ghaemi, E. A. (2012). Extended spectrum beta lactamase 
producing E. coli isolated from Gorgan, North of Iran. Medical Laboratory Journal; 6(1), 51-58. 
64. Oliver, A., Coque, T. M., Alonso, D., Valverde, A., Baquero, F., and Cantón, R. (2005). CTX-M-10 linked to a phage-
related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrobial agents and 
chemotherapy; 49(4), 1567-1571. 
65. Pakzad, I., Ghafourian, S., Taherikalani, M., Abtahi, H., Rahbar, M., and Mansory Jamshidi, N. (2011). Qnr prevalence 
in extended spectrum beta-lactamases (ESBLs) and none-ESBLs producing Escherichia coli isolated from urinary tract 
infections in central of Iran. Iranian journal of basic medical sciences; 14(5), 458-464. 
66. Parsania, S., and Sohrabpour, M. (2014). Prevalence of CTX-M-15β-lactamase Genes in Escherichia coli Strains Using 
PCR. Journal of Mazandaran University of Medical Sciences; 24(116), 58-62. 
67. Paterson, D. L., and Bonomo, R. A. (2005). Extended-spectrum β-lactamases: a clinical update. Clinical microbiology 
reviews; 18(4), 657-686. 
68. Peerayeh, S. N., Eslami, M., Memariani, M., and Siadat, S. D. (2013). High prevalence of blaCTX-M-1 group 
extended-spectrum β-lactamase genes in Escherichia coli isolates from Tehran. Jundishapur Journal of 
Microbiology; 6(7). 
69. Peymani, A., Marandi, M., and Najafipour, R. (2014). Prevalence of OXA-1 type ESBLs amonge clinical isolates of 
Entrobacter cloacae collected from Qazvin Hospitals, Iran. Iranian Journal of Public Health; 43(2), 84. 
70. Rafiee, R., Eftekhar, F., and Tabatabaei, S. A. (2014). Prevalence of Extended-Spectrum and Metallo β-Lactamase 
Production in AmpC β-Lactamase Producing Pseudomonas aeruginosa Isolates From Burns. Jundishapur journal of 
microbiology; 7(9), e16436-e16436. 
71. Ramazanzadeh, R. (2010). Etiologic agents and extended-spectrum beta-lactamase production in urinary tract 
infections in Sanandaj, Iran. Eastern Journal of Medicine; 15(2), 57. 
72. Ranjbar, R. E. Z. A., Ahmadnezhad, B. A. H. M. A. N., and Jonaidi, N. E. M. A. T. O. L. L. A. H. (2014). The 
Prevalance of Beta Lactamase Producing Escherichia coli Strains Isolated from the Urine Samples in Valiasr 
Hospital. Biomed & Pharmacol J; 7, 425-431. 
73. Rezai, M. S., Salehifar, E., Rafiei, A., Langaee, T., Rafati, M., Shafahi, K., and Eslami, G. (2015). Characterization of 
multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in 
North of Iran. BioMed research international; 2015. 
74. Riyahi Zaniani, F., Meshkat, Z., Naderi Nasab, M., Khaje-Karamadini, M., Ghazvini, K., Rezaee, A., and Darban 
Hoseini, M. (2012). The prevalence of TEM and SHV genes among extended-spectrum beta-lactamases producing 
Escherichia coli and Klebsiella pneumoniae. Iranian journal of basic medical sciences; 15(1), 654-660. 
75. Rizi, K. S., Peerayeh, S. N., Bakhshi, B., and Rahbar, M. (2015). Prevalence of the blaCTX-M-1 group and their 
transferability in resistant clinical isolates of Salmonella serogroups from several hospitals of Tehran. Iranian journal of 
microbiology; 7(4), 203. 
76. Saeidi, S., Alavi-Naini, R., and Shayan, S. (2014). Antimicrobial susceptibility and distribution of tem and ctx-m genes 
among esbl-producing Klebsiella pneumoniae and Pseudomonas aeruginosa causing urinary tract infections. Zahedan 
Journal of Research in Medical Sciences; 16(4), 1-5. 
77. Safari, M., Nejad, A. S. M., Bahador, A., Jafari, R., and Alikhani, M. Y. (2015). Prevalence of ESBL and MBL 
encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU). Saudi journal 
of biological sciences; 22(4), 424-429. 
78. Safari, M., Shojapour, M., Akbari, M., Pourbabaee, A., and Abtahi, H. (2013). Dissemination of CTX-M-type beta-
lactamase among clinical isolates of Enterobacteriaceae in Markazi province, Iran. Jundishapur Journal of 
Microbiology; 6(8). 
Leylabadlo et al., Afr., J. Infect. Dis. (2017) 11 (2): 39-53 
https://doi.org/10.21010/ajid.v11i2.6  
 
53 
 
79. Shacheraghi, F., Shakibaie, M. R., and Noveiri, H. (2010). Molecular identification of ESBL Genes blaGES-blaVEB-
blaCTX-M blaOXA-blaOXA-4, blaOXA-10 andblaPER-in Pseudomonas aeruginosa strains isolated from burn 
patients by PCR, RFLP and sequencing techniques. Int J Biol life Sci; 3(6), 138-42. 
80. Shahandeh, Z., Sadighian, F., and Rekabpou, K. B. (2015). Phenotypic study of Extended-spectrum beta-lactamase, 
AmpC and Carbapenemase among E. coli clinical isolates in affiliated hospitals of Babol University of Medical 
Sciences. International Journal of Health System and Disaster Management; 3(2), 74. 
81. SHAHCHERAGHI, F., Nasiri, S., and Noveiri, H. (2009). Detection of extended-spectrum β-lactamases 
(ESBLs). Archives of Clinical Infectious Diseases; 4(2), 65-70. 
82. Shahcheraghi, F., Nikbin, V. S., and Feizabadi, M. M. (2009). Prevalence of ESBLs genes among multidrug-resistant 
isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microbial Drug Resistance; 15(1), 37-39.  
83. SHAMS, E., Firoozeh, F., Moniri, R., and Zibaei, M. (2015). Prevalence of plasmid-mediated quinolone resistance 
genes among extended-spectrum β-Lactamase-producing Klebsiella pneumoniae human isolates in Iran. Journal of 
pathogens; 2015. 
84. Shams, F., Hasani, A., Rezaee, M. A., Nahaie, M. R., Hasani, A., Haghi, M. H. S. B., and Arbatan, A. E. (2015). 
Carriage of Class 1 and 2 Integrons in Quinolone, Extended-Spectrum-β-Lactamase-Producing and Multi Drug 
Resistant E. coli and K. pneumoniae: High Burden of Antibiotic Resistance. Advanced pharmaceutical bulletin; 5(3), 
335. 
85. Sharif, M., Mirnejad, R., and Amirmozafari, N. (2014). Molecular identification of TEM and SHV extended spectrum 
β-lactamase in clinical isolates of Acinetobacter baumannii from Tehran hospitals. J Gen Microb Immun; 2, 1-9. 
86. Shayan, S., and Bokaeian, M. (2015). Detection of ESBL-and AmpC-producing E. coli isolates from urinary tract 
infections. Advanced biomedical research, 4. 
87. Tafti, A., Zandi, H., Vakli, M., Mousavi, S. M., and Zarei, M. (2014). Frequency of β-lactamase and metallo-β-
lactamase in Pseudomonas aeruginosa strains isolated from burn wounds in Yazd burn hospital during 2011-
2012. KAUMS Journal (FEYZ) ; 18(2), 167-174. 
88. Tajbakhsh, M., Migura, L. G., Rahbar, M., Svendsen, C. A., Mohammadzadeh, M., Zali, M. R., and Hendriksen, R. S. 
(2012). Antimicrobial-resistant Shigella infections from Iran: an overlooked problem?. Journal of antimicrobial 
chemotherapy; 67(5), 1128-1133.  
89. Tavajjohi, Z., Moniri, R., and Khorshidi, A. (2011). Detection and characterization of multidrug resistance and 
extended-spectrum-beta-lactamase-producing (ESBLS) Pseudomonas aeruginosa isolates in teaching hospital. African 
Journal of Microbiology Research; 5(20), 3223-3228. 
90. Vali, P., Shahcheraghi, F., Seyfipour, M., Zamani, M. A., Allahyar, M. R., and Feizabadi, M. M. (2014). Phenotypic 
and genetic characterization of carbapenemase and ESBLs producing gram-negative bacteria (GNB) isolated from 
patients with cystic fibrosis (CF) in Tehran hospitals. Journal of clinical and diagnostic research: JCDR; 8(1), 26. 
91. Yazdi, M. K. S., Dallal, M. M. S., Mirzael, H. M. A., Sabbaghi, A., Mehrabadi, J. F., Lari, A. R., and Bakhtiari, R. 
(2011). Molecular detection of TEM broad spectrum β-lactamase in clinical isolates of Escherichia coli. African 
Journal of Biotechnology; 10(46), 9454-9458. 
92. Zadegan, H. H., Ramazanzadeh, R., and Hasany, A. (2009). Cross-sectional study of extended spectrum beta-lactamase 
producing gram-negative bacilli from clinical cases in Khorramabad, Iran. Iranian Journal of Microbiology; 1(3), 16-
19. 
93. Zaniani, F., Meshkat, Z., Naderi Nasab, M., Khaje-Karamadini, M., Ghazvini, K., Rezaee, A., and Darban Hoseini, M. 
(2012). The prevalence of TEM and SHV genes among extended-spectrum beta-lactamases producing Escherichia coli 
and Klebsiella pneumoniae. Iranian journal of basic medical sciences; 15(1), 654-660. 
94. Zowawi, H. M., Balkhy, H. H., Walsh, T. R., and Paterson, D. L. (2013). β-Lactamase production in key gram-
negative pathogen isolates from the Arabian Peninsula. Clinical microbiology reviews; 26(3), 361-380. 
